26.30
price up icon0.46%   0.12
 
loading
Tema Oncology Etf stock is traded at $26.30, with a volume of 2,204. It is up +0.46% in the last 24 hours and down -8.27% over the past month.
See More
Previous Close:
$26.18
Open:
$26.17
24h Volume:
2,204
Relative Volume:
0.71
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-5.60%
1M Performance:
-8.27%
6M Performance:
-4.29%
1Y Performance:
+13.73%
1-Day Range:
Value
$26.14
$26.32
1-Week Range:
Value
$25.84
$27.92
52-Week Range:
Value
$22.85
$30.11

Tema Oncology Etf Stock (CANC) Company Profile

Name
Name
Tema Oncology Etf
Name
Phone
-
Name
Address
-
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
CANC's Discussions on Twitter

Compare CANC with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
CANC 26.30 0 0 0 0 0.00
VTI 293.00 417.53B 0 0 0 0.00
SPY 590.50 372.57B 0 0 0 0.00
IVV 593.44 253.41B 0 0 0 0.00
VB 249.78 160.59B 0 0 0 0.00
QQQ 503.17 124.43B 0 0 0 0.00

Tema Oncology Etf Stock (CANC) Latest News

pulisher
Nov 17, 2024

(CANC) Investment Analysis - Stock Traders Daily

Nov 17, 2024
pulisher
Nov 15, 2024

Pacer Data and Digital Revolution ETF (TRFK) Institutional Ownership 2024 - MarketBeat

Nov 15, 2024
pulisher
Nov 07, 2024

(CANC) Technical Pivots with Risk Controls - Stock Traders Daily

Nov 07, 2024
pulisher
Nov 03, 2024

7 Best-Performing Biotech ETFs for November 2024 - NerdWallet

Nov 03, 2024
pulisher
Oct 29, 2024

The 5 Best Biotech ETFs of 2024 - TradingView

Oct 29, 2024
pulisher
Oct 14, 2024

5 Small-cap Biotech ETFs to Watch (Updated 2024) - Investing News Network

Oct 14, 2024
pulisher
Oct 06, 2024

(CANC) Trading Advice - Stock Traders Daily

Oct 06, 2024
pulisher
Sep 27, 2024

Thrivent Financial for Lutherans Invests $8.62 Million in Tema Oncology ETF (NASDAQ:CANC) - Defense World

Sep 27, 2024
pulisher
Sep 27, 2024

National Bankshares Cuts Lucero Energy (CVE:LOU) Price Target to C$0.75 - Defense World

Sep 27, 2024
pulisher
Sep 25, 2024

(CANC) Technical Data - Stock Traders Daily

Sep 25, 2024
pulisher
Sep 02, 2024

Tema Oncology ETF (NASDAQ:CANC) Short Interest Update - Defense World

Sep 02, 2024
pulisher
Aug 30, 2024

Where are the Opportunities in (CANC) - Stock Traders Daily

Aug 30, 2024
pulisher
Aug 13, 2024

Tema Oncology ETF (NASDAQ:CANC) Sees Large Decrease in Short Interest - Defense World

Aug 13, 2024
pulisher
Aug 07, 2024

When the Price of (CANC) Talks, People Listen - Stock Traders Daily

Aug 07, 2024
pulisher
Jul 25, 2024

Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says - CNBC

Jul 25, 2024
pulisher
Jul 25, 2024

Tema American Reshoring ETF: Benefiting From The Return Of U.S. Manufacturing - Seeking Alpha

Jul 25, 2024
pulisher
Jul 07, 2024

EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO - Quantisnow

Jul 07, 2024
pulisher
Jun 12, 2024

5 Small-cap Biotech ETFs to Watch (Updated 2024) | INN - Investing News Network

Jun 12, 2024
pulisher
May 23, 2024

Tema ETFs CIO on Investment Opportunities in Biotech - Opto RoW

May 23, 2024
pulisher
May 17, 2024

9 Best Biotech ETFs for 2024 - MSN

May 17, 2024
pulisher
Apr 25, 2024

How Big Pharma Is Taking A Page Out Of Novartis' Playbook - Investor's Business Daily

Apr 25, 2024
pulisher
Apr 22, 2024

10 Best Performing Biotech ETFs in 2024 - Yahoo Finance

Apr 22, 2024
pulisher
Apr 18, 2024

Investment Surge in Healthcare ETFs Amidst Weight-Loss Drug Revolution - The PiPa News

Apr 18, 2024
pulisher
Apr 09, 2024

11 Best Biotech ETFs To Buy - Yahoo Finance

Apr 09, 2024
pulisher
Apr 08, 2024

Healthcare ETFs for the Weight-Loss Drug Boom & Beyond - Yahoo Finance

Apr 08, 2024
pulisher
Mar 27, 2024

Viking Therapeutics' weight-loss tablet shows promise in small study - ETHealthWorld

Mar 27, 2024
pulisher
Jan 22, 2024

Is Gilead's 10% Crash — Resulting In A Failed Breakout — An Overreaction? - Investor's Business Daily

Jan 22, 2024
pulisher
Dec 04, 2023

Sanofi CEO under pressure to woo investors after spending shock - Reuters.com

Dec 04, 2023
pulisher
Dec 01, 2023

EXCLUSIVE: Tema ETFs' Innovative Thematic Investing Approach Targets New Opportunities Beyond The Fads - Markets Insider

Dec 01, 2023
pulisher
Nov 22, 2023

Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund - Reuters

Nov 22, 2023
pulisher
Sep 06, 2023

12 Best Healthcare ETFs To Buy - Yahoo Finance

Sep 06, 2023
pulisher
Sep 01, 2023

Investing in Oncology: A Biotech Revolution in Research, Diagnosis, and Treatment of Cancer - Nasdaq

Sep 01, 2023
pulisher
Aug 28, 2023

Oncology Market's Huge Potential Puts These Stocks in Focus - Yahoo Finance

Aug 28, 2023
pulisher
Aug 21, 2023

Royalties and cancer treatments: Thematic ETFs take new directions - InvestmentNews

Aug 21, 2023
pulisher
Aug 19, 2023

How BlackRock’s Rick Rieder is steering his active fixed-income ETF as bond funds struggle - MarketWatch

Aug 19, 2023
pulisher
Aug 18, 2023

This Week in ETFs: 2 Funds Launch From Tema - ETFdb.com

Aug 18, 2023
pulisher
Aug 17, 2023

Tema Launches Two Innovative, Active ETF Thematic Strategies: Oncology & Global Royalties - Business Wire

Aug 17, 2023
pulisher
May 11, 2023

Tema launches three innovative, professionally managed thematic ETFs: American Reshoring, Luxury, & Monopolies and Oligopolies - Business Wire

May 11, 2023
pulisher
May 08, 2023

Tema, Backed by Index, Accel and Zinal, Expands Access to Innovative Investment Themes Through Launch of Active ETF Platform - Business Wire

May 08, 2023
pulisher
Mar 02, 2022

Ukroboronprom to Repair Captured Russian Tanks for Use by Ukrainian Army - Defense World

Mar 02, 2022
pulisher
Oct 09, 2021

Pyxis Oncology (PYXS) Stock Price, News & Analysis - MarketBeat

Oct 09, 2021
pulisher
May 21, 2021

Getting in on global luxury - ETF Strategy

May 21, 2021
pulisher
Feb 05, 2021

Terns Pharmaceuticals (TERN) Stock Price, News & Analysis - MarketBeat

Feb 05, 2021
pulisher
Aug 10, 2020

Relay Therapeutics (RLAY) Stock Price, News & Analysis - MarketBeat

Aug 10, 2020
pulisher
Aug 01, 2019

Genmab A/S (GMAB) Stock Price, News & Analysis - MarketBeat

Aug 01, 2019
pulisher
Oct 01, 2018

Arvinas (ARVN) Stock Price, News & AnalysisNASDAQ - MarketBeat

Oct 01, 2018
pulisher
Oct 03, 2016

Cogent Biosciences (COGT) Stock Price, News & Analysis - MarketBeat

Oct 03, 2016
pulisher
Jun 16, 2015

Exelixis (EXEL) Stock Price, News & AnalysisNASDAQ - MarketBeat

Jun 16, 2015

Tema Oncology Etf Stock (CANC) Financials Data

There is no financial data for Tema Oncology Etf (CANC). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
exchange_traded_fund VTV
$176.62
price up icon 0.20%
exchange_traded_fund VUG
$403.47
price down icon 0.08%
exchange_traded_fund IJH
$64.71
price up icon 0.61%
exchange_traded_fund EFA
$77.24
price down icon 0.27%
exchange_traded_fund IWF
$392.76
price down icon 0.16%
exchange_traded_fund QQQ
$503.17
price down icon 0.06%
Cap:     |  Volume (24h):